Sanaz Gabery

1.6k total citations
25 papers, 718 citations indexed

About

Sanaz Gabery is a scholar working on Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism and Neurology. According to data from OpenAlex, Sanaz Gabery has authored 25 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Neurology. Recurrent topics in Sanaz Gabery's work include Genetic Neurodegenerative Diseases (10 papers), Neurological disorders and treatments (5 papers) and Pituitary Gland Disorders and Treatments (5 papers). Sanaz Gabery is often cited by papers focused on Genetic Neurodegenerative Diseases (10 papers), Neurological disorders and treatments (5 papers) and Pituitary Gland Disorders and Treatments (5 papers). Sanaz Gabery collaborates with scholars based in Sweden, Australia and Denmark. Sanaz Gabery's co-authors include Åsa Petersén, Glenda M. Halliday, Karen E. Murphy, Deniz Kirik, Olivier Piguet, Rachel Y. Cheong, John R. Hodges, Bonnie Lam, Elizabeth McCusker and Clement T. Loy and has published in prestigious journals such as The Lancet, PLoS ONE and Annals of Neurology.

In The Last Decade

Sanaz Gabery

25 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanaz Gabery Sweden 14 223 221 190 169 166 25 718
Helena Frielingsdorf Sweden 9 328 1.5× 38 0.2× 182 1.0× 34 0.2× 173 1.0× 17 880
Meera Purushottam India 19 346 1.6× 170 0.8× 458 2.4× 27 0.2× 154 0.9× 88 983
Aude Milet France 11 221 1.0× 67 0.3× 140 0.7× 51 0.3× 91 0.5× 15 511
Christine H. Block United States 17 331 1.5× 48 0.2× 269 1.4× 238 1.4× 161 1.0× 26 1.1k
Shuken Boku Japan 13 275 1.2× 121 0.5× 215 1.1× 24 0.1× 84 0.5× 19 943
Daniel Radzicki United States 8 230 1.0× 78 0.4× 122 0.6× 21 0.1× 315 1.9× 9 642
Paulette B. Goforth United States 17 232 1.0× 211 1.0× 318 1.7× 88 0.5× 178 1.1× 18 982
Benjamin A. Packard United States 16 163 0.7× 62 0.3× 107 0.6× 93 0.6× 116 0.7× 22 813
Hisamasa Imai Japan 18 414 1.9× 602 2.7× 105 0.6× 47 0.3× 109 0.7× 41 896
Hilarie C. Tomasiewicz United States 9 570 2.6× 35 0.2× 361 1.9× 52 0.3× 80 0.5× 10 915

Countries citing papers authored by Sanaz Gabery

Since Specialization
Citations

This map shows the geographic impact of Sanaz Gabery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanaz Gabery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanaz Gabery more than expected).

Fields of papers citing papers by Sanaz Gabery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanaz Gabery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanaz Gabery. The network helps show where Sanaz Gabery may publish in the future.

Co-authorship network of co-authors of Sanaz Gabery

This figure shows the co-authorship network connecting the top 25 collaborators of Sanaz Gabery. A scholar is included among the top collaborators of Sanaz Gabery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanaz Gabery. Sanaz Gabery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casadei, Nicolas, Sanaz Gabery, João M. N. Duarte, et al.. (2025). TDP-43 overexpression in the hypothalamus drives neuropathology, dysregulates metabolism and impairs behavior in mice. Acta Neuropathologica Communications. 13(1). 119–119. 1 indexed citations
2.
3.
4.
5.
Gabery, Sanaz, et al.. (2023). Effects of mutant huntingtin in oxytocin neurons on non‐motor features of Huntington's disease. Neuropathology and Applied Neurobiology. 49(2). e12891–e12891. 2 indexed citations
6.
Aroda, Vanita R., Jens Aberle, Erik Christiansen, et al.. (2023). Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial. The Lancet. 402(10403). 693–704. 67 indexed citations
7.
Cheong, Rachel Y., et al.. (2022). Oxytocin in Huntington’s disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia. Frontiers in Molecular Neuroscience. 15. 984317–984317. 6 indexed citations
8.
Gabery, Sanaz, Rebekah M. Ahmed, Jashelle Caga, et al.. (2021). Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology. 47(7). 979–989. 38 indexed citations
9.
Gabery, Sanaz, Rachel Y. Cheong, Barbara Baldo, et al.. (2021). Early white matter pathology in the fornix of the limbic system in Huntington disease. Acta Neuropathologica. 142(5). 791–806. 12 indexed citations
10.
Fjalldal, Sigridur, Lars Rylander, Danielle van Westen, et al.. (2020). Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood‐onset craniopharyngioma. Clinical Endocrinology. 94(1). 48–57. 3 indexed citations
11.
Cheong, Rachel Y., Sanaz Gabery, & Åsa Petersén. (2019). The Role of Hypothalamic Pathology for Non-Motor Features of Huntington’s Disease. Journal of Huntington s Disease. 8(4). 375–391. 23 indexed citations
12.
Gabery, Sanaz, Kasper Marstal, Tomas Alanentalo, et al.. (2018). Integrated Brain Atlas for Unbiased Mapping of Nervous System Effects Following Liraglutide Treatment. Scientific Reports. 8(1). 10310–10310. 69 indexed citations
13.
Fjalldal, Sigridur, Cecilia Follin, Sanaz Gabery, et al.. (2018). Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity. International Journal of Obesity. 43(3). 533–544. 24 indexed citations
14.
Fjalldal, Sigridur, Cecilia Follin, Sanaz Gabery, et al.. (2017). Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity. Endocrine Abstracts. 3 indexed citations
15.
Follin, Cecilia, Sanaz Gabery, Åsa Petersén, et al.. (2016). Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy. PLoS ONE. 11(1). e0147575–e0147575. 12 indexed citations
16.
Gabery, Sanaz, Nellie Georgiou‐Karistianis, Sofia Lundh, et al.. (2015). Volumetric Analysis of the Hypothalamus in Huntington Disease Using 3T MRI: The IMAGE-HD Study. PLoS ONE. 10(2). e0117593–e0117593. 43 indexed citations
17.
18.
Petersén, Åsa & Sanaz Gabery. (2012). Hypothalamic and Limbic System Changes in Huntington's Disease. Journal of Huntington s Disease. 1(1). 5–16. 41 indexed citations
19.
Gabery, Sanaz, Karen E. Murphy, Clement T. Loy, et al.. (2010). Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses. Acta Neuropathologica. 120(6). 777–788. 91 indexed citations
20.
Piguet, Olivier, Åsa Petersén, Bonnie Lam, et al.. (2010). Eating and hypothalamus changes in behavioral‐variant frontotemporal dementia. Annals of Neurology. 69(2). 312–319. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helena Frielingsdorf Breakdown of academic impact, for papers by Meera Purushottam Breakdown of academic impact, for papers by Aude Milet Breakdown of academic impact, for papers by Christine H. Block Breakdown of academic impact, for papers by Shuken Boku Breakdown of academic impact, for papers by Daniel Radzicki Breakdown of academic impact, for papers by Paulette B. Goforth Breakdown of academic impact, for papers by Benjamin A. Packard Breakdown of academic impact, for papers by Hisamasa Imai Breakdown of academic impact, for papers by Hilarie C. Tomasiewicz
Rankless by CCL
2026